Stanford University professor Chaitan Khosla and his team have already discovered how to activate TG2, and now they are releasing their findings on how to deactivate it. Deactivate celiac disease—can you imagine?! Say hello to the ERp57 enzyme, the solution to deactivating TG2—and, possibly, celiac. Medical News Today reports that “…the research team is looking into existing drugs that may be able to target this newly discovered switch.” That’s right—an actual cure that stops the immune response in celiac patients for good may be in the works.
- Quote from Aug. 7 2018 Article in Gluten Free Living